Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis. 1998

A Furusu, and M Miyazaki, and K Abe, and S Tsukasaki, and K Shioshita, and O Sasaki, and K Miyazaki, and Y Ozono, and T Koji, and T Harada, and H Sakai, and S Kohno
Second Department of Internal Medicine, Nagasaki University School of Medicine, Japan. furusua-ngs@umin.u-tokyo.ac.jp

The presence of nitric oxide (NO) in the kidney has been implicated in the pathogenesis of human glomerulonephritis. However, the exact type of glomerular cells that express NO synthase (NOS) and the NOS isoform involved in the local production of NO has not been identified in the human diseased kidney. We examined the expression of three isoforms of NOS, inducible NOS (iNOS), endothelial NOS (eNOS) and brain NOS (bNOS) in the renal tissue of patients with IgA nephropathy (IgAN, N = 10), lupus nephritis (LN, N = 5), membranous nephropathy (MN, N = 5) and minimal change nephrotic syndrome (MCNS, N = 5). Sections were immunostained and the correlation between the expression of each NOS and the degree of glomerular injury in that section was also examined. Normal portions of surgically resected kidneys served as controls. eNOS was present in glomerular endothelial cells and endothelium of cortical vessels in the control and diseased kidneys. iNOS was localized in mesangial cells, glomerular epithelial cells and infiltrating cells in the diseased glomeruli, whereas immunostaining for iNOS was hardly detected in control kidneys. In addition, the expression pattern of eNOS in each glomerulus was the reverse of that of iNOS. In IgAN and LN, the extent of staining for eNOS correlated negatively with the degree of glomerular injury, while the extent of staining for iNOS correlated positively with the degree of glomerular injury in the same tissues. bNOS was not detected in normal or nephritic glomeruli. Our results indicate the presence of a NO pathway in human diseased kidney, and suggest that NO derived from eNOS and iNOS may be involved in the progression of renal diseases and that NO derived from each NOS may play an important role in different way in human inflamed glomeruli.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005921 Glomerulonephritis Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY. Bright Disease,Kidney Scarring,Glomerulonephritides,Scarring, Kidney
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013194 Staining and Labeling The marking of biological material with a dye or other reagent for the purpose of identifying and quantitating components of tissues, cells or their extracts. Histological Labeling,Staining,Histological Labelings,Labeling and Staining,Labeling, Histological,Labelings, Histological,Stainings
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions
D052247 Nitric Oxide Synthase Type II A CALCIUM-independent subtype of nitric oxide synthase that may play a role in immune function. It is an inducible enzyme whose expression is transcriptionally regulated by a variety of CYTOKINES. INOS Enzyme,Inducible NOS Protein,Inducible Nitric Oxide Synthase,NOS-II,Nitric Oxide Synthase II,Nitric Oxide Synthase, Type II,NOS II
D052250 Nitric Oxide Synthase Type III A CALCIUM-dependent, constitutively-expressed form of nitric oxide synthase found primarily in ENDOTHELIAL CELLS. ECNOS Enzyme,ENOS Enzyme,Endothelial Constitutive Nitric Oxide Synthase,Endothelial Nitric Oxide Synthase,Nitric Oxide Synthase, Type III

Related Publications

A Furusu, and M Miyazaki, and K Abe, and S Tsukasaki, and K Shioshita, and O Sasaki, and K Miyazaki, and Y Ozono, and T Koji, and T Harada, and H Sakai, and S Kohno
September 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
A Furusu, and M Miyazaki, and K Abe, and S Tsukasaki, and K Shioshita, and O Sasaki, and K Miyazaki, and Y Ozono, and T Koji, and T Harada, and H Sakai, and S Kohno
October 1999, Ryumachi. [Rheumatism],
A Furusu, and M Miyazaki, and K Abe, and S Tsukasaki, and K Shioshita, and O Sasaki, and K Miyazaki, and Y Ozono, and T Koji, and T Harada, and H Sakai, and S Kohno
November 2002, Journal of hepatology,
A Furusu, and M Miyazaki, and K Abe, and S Tsukasaki, and K Shioshita, and O Sasaki, and K Miyazaki, and Y Ozono, and T Koji, and T Harada, and H Sakai, and S Kohno
May 2001, Current protocols in toxicology,
A Furusu, and M Miyazaki, and K Abe, and S Tsukasaki, and K Shioshita, and O Sasaki, and K Miyazaki, and Y Ozono, and T Koji, and T Harada, and H Sakai, and S Kohno
October 1995, The American journal of pathology,
A Furusu, and M Miyazaki, and K Abe, and S Tsukasaki, and K Shioshita, and O Sasaki, and K Miyazaki, and Y Ozono, and T Koji, and T Harada, and H Sakai, and S Kohno
January 1998, Methods in molecular biology (Clifton, N.J.),
A Furusu, and M Miyazaki, and K Abe, and S Tsukasaki, and K Shioshita, and O Sasaki, and K Miyazaki, and Y Ozono, and T Koji, and T Harada, and H Sakai, and S Kohno
January 1997, Journal of investigative surgery : the official journal of the Academy of Surgical Research,
A Furusu, and M Miyazaki, and K Abe, and S Tsukasaki, and K Shioshita, and O Sasaki, and K Miyazaki, and Y Ozono, and T Koji, and T Harada, and H Sakai, and S Kohno
February 1997, The Journal of dermatology,
A Furusu, and M Miyazaki, and K Abe, and S Tsukasaki, and K Shioshita, and O Sasaki, and K Miyazaki, and Y Ozono, and T Koji, and T Harada, and H Sakai, and S Kohno
January 1997, Molecular human reproduction,
A Furusu, and M Miyazaki, and K Abe, and S Tsukasaki, and K Shioshita, and O Sasaki, and K Miyazaki, and Y Ozono, and T Koji, and T Harada, and H Sakai, and S Kohno
August 1997, American journal of surgery,
Copied contents to your clipboard!